Korea Infectious Disease Research: Lee Kun-hee Symposium 2024

0 comments

South Korea Bolsters Infectious Disease Response with New Initiatives

South Korea is strengthening its national infectious disease response system through a series of new measures, including accelerated vaccine development and real-time clinical data analysis. These initiatives are supported by a 1 trillion won (approximately $770 million USD) donation from the family of the late Lee Kun-hee, chairman of Samsung Electronics, and aim to preemptively address future pandemics.

Lee Kun-hee’s Legacy: Funding a Robust Response System

The donation from the Lee Kun-hee family is being allocated to three key areas: 500 billion won for the construction of a Central Infectious Disease Hospital at the National Medical Center, 100 billion won to expand the infrastructure of the National Institute of Infectious Diseases, and 100 billion won for a project to strengthen overall research capabilities in overcoming infectious diseases.

Real-Time Data Analysis for Faster Response

A core component of the new strategy is the establishment of a ‘National Integrated Infectious Disease Response System.’ This system will analyze clinical data from hospitals nationwide in real-time, breaking down information silos between research institutions and treatment centers. The goal is to secure critical time for responding to outbreaks and enable data-driven, precise quarantine measures.

Accelerated Vaccine Development

The government aims to shorten the vaccine development period to less than 100 days, significantly reducing the time it takes to respond to emerging infectious threats.

International Collaboration and Symposiums

The Korea Centers for Disease Control and Prevention (KCDC) and the National Medical Center recently held the 2nd Lee Kun-hee International Symposium on Strengthening Research Capacity to Overcome Infectious Diseases (LISID) and the 4th Infectious Disease Research Institute International Symposium (IDRIC) on March 26th. These events, attended by representatives from the International Vaccine Institute (IVI), serve as platforms for sharing research findings and fostering collaboration between domestic and international researchers.

The symposiums build upon previous initiatives, including the 1st Lee Kun-hee International Symposium for Infectious Diseases Research (LISID) and the 3rd Infectious Disease Research Institute Cooperation (IDRIC) held in July 2025.

Key Participants

Key figures involved in these efforts include Lim Seung-kwan, head of the Korea Centers for Disease Control and Prevention, and Seo Gil-jun, Director of the National Medical Center. Minister of Health and Welfare, Kyungsil Jeong, also participated.

These combined efforts represent a significant investment in South Korea’s preparedness for future infectious disease challenges, leveraging both domestic resources and international partnerships.

Related Posts

Leave a Comment